Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 29, 2025
Breaking the barriers in effective and safe Toll-like receptor stimulation via nano-immunomodulators for potent cancer immunotherapyYaoqi Li, Yitian Chen, Yong'an Tang, et al.
Iscience|September 15, 2025
Encapsulation of doxorubicin in magnesium acetate liposomes as a pH-sensitive drug carrier for tumor therapyYu Yang, Miaomiao Zhang, Zhiqiang Hong, et al.
Mediators of Inflammation|August 15, 2015
Dexmedetomidine Ameliorate CLP-Induced Rat Intestinal Injury via Inhibition of InflammationYanqing Chen, Liyan Miao, Yusheng Yao, et al.
Chemical Communications (Cambridge, England)|November 21, 2017
A universal genotyping-microarray constructed by ligating a universal fluorescence-probe with SNP-encoded flaps cleaved from multiplex invasive reactionsZhiyao Chen, Liyan Miao, Yunlong Liu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 14, 2026
Absorption, distribution, metabolism, excretion and mass balance of ainuovirine, a non-nucleoside reverse transcriptase inhibitor in humansYuechan Wu, Sheng Ma, Xinming Yun, et al.
Frontiers in Immunology|September 6, 2024
Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assaysXiaoliang Ding, Ling Xue, Mingjun Wang, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2024
Absorption, metabolism, and excretion of oral [14C] radiolabeled donafenib: an open-label, phase I, single-dose study in humansSheng Ma, Ling Yi, YiCong Bian, et al.
Pharmacogenomics|December 19, 2019
Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patientsCheng Xie, Ling Xue, Yuzhen Zhang, et al.
Pharmacogenetics and Genomics|February 19, 2014
The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart diseaseCheng Xie, Xiaoliang Ding, Jie Gao, et al.
Current Drug Metabolism|March 8, 2024
A Phase I Clinical Study of the Pharmacokinetics and Safety of Prusogliptin Tablets in Subjects with Mild to Moderate Hepatic Insufficiency and Normal Liver FunctionHuiting Zhang, Yicong Bian, Weifeng Zhao, et al.
Pageof 14